MYCN and neoplasm: The neuroblastoma oncogenic transcription factor MYCN can also escape the risk of ferroptosis by promoting the expression of system Xc- and some system Xc- inhibitors (ATF3, INFγ) might increase the chance of ferroptosis in tumor cells by reducing the effect of MYCN (78).